Loading...
Pembrolizumab
India Pharmaceutical Trade Intelligence
Who Supplies Pembrolizumab to India from UNITED STATES
India's pembrolizumab imports from UNITED STATES total $135.4K across 49 shipments from 15 foreign suppliers. KREATIVE TECHNOLABS leads with $37.3K in import value; the top 5 suppliers together control 74.5% of this origin. Leading Indian buyers include IPCA LABORATORIES LIMITED. This corridor reflects India's pharmaceutical import demand for pembrolizumab — a diversified sourcing base with multiple active suppliers from UNITED STATES.
Top foreign suppliers (UNITED STATES) — Ranked by import value
KREATIVE TECHNOLABS is the leading Pembrolizumab supplier from UNITED STATES to India, with import value of $37.3K across 16 shipments. The top 5 suppliers — KREATIVE TECHNOLABS, NEW LIFE MEDICALS (USA) INC, SPRING BIO SOLUTION, CELTIS HEALTHCARE LLC, PIERCE BIOTECHNOLOGY,INC. — collectively account for 74.5% of total import value from this origin.
Top foreign suppliers (UNITED STATES)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | KREATIVE TECHNOLABS | $37.3K | 16 | 27.6% |
| 2 | NEW LIFE MEDICALS (USA) INC | $22.4K | 1 | 16.5% |
| 3 | SPRING BIO SOLUTION | $17.8K | 2 | 13.2% |
| 4 | CELTIS HEALTHCARE LLC | $13.5K | 2 | 9.9% |
| 5 | PIERCE BIOTECHNOLOGY,INC. | $9.8K | 11 | 7.2% |
| 6 | M/S. SUN PHARMACEUTICAL INDUSTRIES | $7.2K | 1 | 5.3% |
| 7 | NEW LIFE MEDICALS (USA), INC. | $5.8K | 1 | 4.3% |
| 8 | ESPEE BIOPHARMA & FINECHEM LLC | $5.8K | 1 | 4.3% |
| 9 | M/S. CELTIS HEALTHCARE LLC | $5.6K | 1 | 4.1% |
| 10 | M/S CELLTHEON CORPORATION | $5.0K | 2 | 3.7% |
| 11 | BIO X CELL | $1.8K | 1 | 1.4% |
| 12 | LIFE TECHNOLOGIES LIMITED | $1.0K | 4 | 0.8% |
| 13 | M S SUN PHARMACEUTICAL INDUSTRIES INC | $1.0K | 1 | 0.8% |
| 14 | PIERCE BIOTECHNOLOGY INC | $684 | 2 | 0.5% |
| 15 | ICHORBIO LTD | $478 | 1 | 0.4% |
Showing top 15 of 15 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from UNITED STATES)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | IPCA LABORATORIES LIMITED | $31.0K | 4 | 22.9% |
| 2 | INTAS PHARMACEUTICALS LIMITED | $28.9K | 4 | 21.3% |
| 3 | KRISHGEN BIOSYSTEMS | $26.3K | 15 | 19.4% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $13.2K | 4 | 9.7% |
| 5 | KRISHGEN BIOSYSTEMS PRIVATE LIMITED | $11.5K | 2 | 8.5% |
| 6 | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED | $10.9K | 15 | 8.1% |
| 7 | ZYDUS LIFESCIENCES LIMITED | $5.9K | 1 | 4.3% |
| 8 | KASHIV BIOSCIENCES PRIVATE LIMITED | $5.8K | 1 | 4.3% |
| 9 | BIOGENE INDIA | $1.8K | 1 | 1.4% |
| 10 | ADGYL LIFESCIENCES PRIVATE LIMITED | $107 | 2 | 0.1% |
Import Statistics
- Import Value
- $135.4K
- Shipments
- 49
- Foreign Suppliers
- 15
- Indian Buyers
- 10
- Avg. Shipment
- $2.8K
Other Pembrolizumab Import Origins
Related Analysis
Frequently Asked Questions — Pembrolizumab Imports from UNITED STATES
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Pembrolizumab suppliers from UNITED STATES to India?
The top Pembrolizumab suppliers from UNITED STATES to India include KREATIVE TECHNOLABS, NEW LIFE MEDICALS (USA) INC, SPRING BIO SOLUTION. The leading supplier is KREATIVE TECHNOLABS with import value of $37.3K USD across 16 shipments. India imported Pembrolizumab worth $135.4K USD from UNITED STATES in total across 49 shipments.
QHow much Pembrolizumab does India import from UNITED STATES?
India imported Pembrolizumab worth $135.4K USD from UNITED STATES across 49 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Pembrolizumab from UNITED STATES?
The main Indian buyers of Pembrolizumab sourced from UNITED STATES include IPCA LABORATORIES LIMITED, INTAS PHARMACEUTICALS LIMITED, KRISHGEN BIOSYSTEMS. The largest buyer is IPCA LABORATORIES LIMITED with $31.0K in imports across 4 shipments.
QWhat is the total value of Pembrolizumab imports from UNITED STATES to India?
The total value of Pembrolizumab imports from UNITED STATES to India is $135.4K USD, across 49 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: UNITED STATES to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Pembrolizumab.
- 2.Supplier/Buyer Matching: 15 foreign suppliers from UNITED STATES and 10 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $135.4K aggregated from 49 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
49 Verified Shipments
15 suppliers, 10 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists